A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer
- PMID: 31402072
- DOI: 10.1016/j.ejso.2019.08.003
A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer
Abstract
Background: Axillary lymph node dissection (ALND) in breast cancer patients is infamous for its accompanying morbidity. Selective preservation of upper extremity lymphatic drainage and accompanying lymph nodes crossing the axillary basin - currently resected during a standard ALND - has been proposed as a valuable surgical refinement.
Methods: Peroperative Axillary Reversed Mapping (ARM) was used for selective preservation of upper extremity lymphatic drainage. A multicentre patient- and assessor-blinded randomized study was performed in clinical node negative, sentinel node positive early breast cancer patients. Patients were randomized to undergo either standard-ALND or ARM-ALND. Primary outcome was the presence of surgery-related lymphedema at six, 12 and 24 months post-operatively. Secondary outcomes included patient reported and objective signs and symptoms of lymphedema, pain, paraesthesia, numbness, loss of shoulder mobility, quality of life and axillary recurrence risk.
Results: No significant differences were found between both groups using the water displacement method with respect to measured lymphedema. ARM-ALND resulted in less reported complaints of lymphedema at six, 12 and 24 months postoperatively (p < 0.05). No axillary recurrence was found in both groups.
Conclusions: In contrast to results of volumetric measurement, patient reported outcomes support selective sparing of the upper extremity lymphatic drainage using ARM as valuable surgical refinement in case of ALND in clinically node negative, sentinel node positive early breast cancer. If completion ALND in clinically node negative, sentinel node positive early breast cancer is considered, selective sparing of upper extremity axillary lymphatics by implementing ARM should be carried out in order to reduce morbidity.
Keywords: Axillary lymph node dissection; Axillary reverse mapping; Breast cancer; Lymphedema.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
Comment in
-
Quality of Life and Limb: Reducing Lymphedema Risk After Breast Cancer Therapy.Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):225-229. doi: 10.1016/j.ijrobp.2019.10.033. Int J Radiat Oncol Biol Phys. 2020. PMID: 31928634 No abstract available.
Similar articles
-
The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.Trials. 2013 Apr 25;14:111. doi: 10.1186/1745-6215-14-111. Trials. 2013. PMID: 23782712 Free PMC article. Clinical Trial.
-
Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial.Int J Surg. 2020 Mar;75:174-178. doi: 10.1016/j.ijsu.2020.01.152. Epub 2020 Feb 12. Int J Surg. 2020. PMID: 32059974 Clinical Trial.
-
Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.World J Surg Oncol. 2020 Jun 1;18(1):118. doi: 10.1186/s12957-020-01886-9. World J Surg Oncol. 2020. PMID: 32482174 Free PMC article.
-
Axillary reverse mapping (ARM): where to go.Breast Cancer. 2019 Jan;26(1):1-10. doi: 10.1007/s12282-018-0886-0. Epub 2018 Jun 30. Breast Cancer. 2019. PMID: 29961238 Review.
-
Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.Expert Rev Anticancer Ther. 2014 Jul;14(7):771-81. doi: 10.1586/14737140.2014.896209. Epub 2014 Mar 13. Expert Rev Anticancer Ther. 2014. PMID: 24621187 Review.
Cited by
-
The effectiveness of axillary reverse mapping in preventing breast cancer-related lymphedema: a meta-analysis based on randomized controlled trials.Gland Surg. 2021 Apr;10(4):1447-1459. doi: 10.21037/gs-21-186. Gland Surg. 2021. PMID: 33968696 Free PMC article.
-
Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.Breast. 2020 Oct;53:189-200. doi: 10.1016/j.breast.2020.08.007. Epub 2020 Aug 18. Breast. 2020. PMID: 32858404 Free PMC article.
-
Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program.Front Oncol. 2024 Jul 16;14:1418610. doi: 10.3389/fonc.2024.1418610. eCollection 2024. Front Oncol. 2024. PMID: 39081716 Free PMC article.
-
The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC Progression via Controlling the TGF-β Signaling Pathway.Front Oncol. 2021 Jun 9;11:654472. doi: 10.3389/fonc.2021.654472. eCollection 2021. Front Oncol. 2021. PMID: 34178640 Free PMC article.
-
Axillary Reverse Mapping in Patients Undergoing Axillary Lymph Node Dissection: A Single Institution Experience From India.Cureus. 2021 Jul 18;13(7):e16462. doi: 10.7759/cureus.16462. eCollection 2021 Jul. Cureus. 2021. PMID: 34422491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical